Aurinia Pharmaceuticals Inc. - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
AUPH Nasdaq 2836 www.auriniapharma.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Aurinia Pharmaceuticals Inc.

Results: Aurinia Pharmaceuticals Inc. Beat Earnings Expectations And Analysts Now Have New Forecasts - Nov 8th, 2025 6:02 am
Can Aurinia (AUPH) Run Higher on Rising Earnings Estimates? - Nov 7th, 2025 10:20 am
Aurinia Pharmaceuticals (AUPH) Profitability Milestone Reinforces Bullish Growth and Valuation Narratives - Nov 5th, 2025 3:06 am
Aurinia Pharmaceuticals Inc (AUPH) Q3 2025 Earnings Call Highlights: Strong Lupkynis Sales and ... - Nov 4th, 2025 2:05 pm
Aurinia Pharmaceuticals (AUPH) Surpasses Q3 Earnings and Revenue Estimates - Nov 4th, 2025 5:10 am
Aurinia: Q3 Earnings Snapshot - Nov 4th, 2025 4:11 am
Aurinia Pharmaceuticals Reports Financial Results for the Three and Nine Months Ended September 30, 2025 and Provides Update on Recent Business Progress - Nov 4th, 2025 4:00 am
Sector Update: Health Care Stocks Decline in Afternoon Trading - Nov 3rd, 2025 11:59 am
Update: Aurinia Pharmaceuticals Reportedly Files Lawsuit Against US FDA Official - Nov 3rd, 2025 9:42 am
Aurinia Pharmaceuticals Reportedly Files Lawsuit Against US FDA Official - Nov 3rd, 2025 9:00 am
Aurinia Pharmaceuticals to Report Financial Results for the Three and Nine Months Ended September 30, 2025 and Provide Update on Recent Business Progress on November 4, 2025 - Nov 3rd, 2025 4:00 am
Tidmarsh resigns from CDER; Kenvue to sell to Kimberly-Clark - Nov 3rd, 2025 3:00 am
FDA Official Steps Down, Sued by Drugmaker - Nov 2nd, 2025 5:59 pm
Is There An Opportunity With Aurinia Pharmaceuticals Inc.'s (NASDAQ:AUPH) 49% Undervaluation? - Nov 1st, 2025 6:17 am
Xencor Stock Earns Relative Strength Rating Upgrade - Oct 16th, 2025 11:40 am
Aurinia Announces Upcoming Presentations of New Data on LUPKYNIS® at American College of Rheumatology Convergence and American Society of Nephrology Kidney Week 2025 - Oct 15th, 2025 4:00 am
Does Aurinia’s Latest Share Spike Reflect Its True Value After Recent Pipeline Updates? - Oct 10th, 2025 10:14 pm
Scholar Rock Holding Stock Scores RS Rating Upgrade - Oct 8th, 2025 11:05 am
FDA official’s comments spark Aurinia sell-off; Halozyme buys a biotech - Oct 1st, 2025 4:00 am
Sector Update: Health Care Stocks Climb Late Afternoon - Sep 30th, 2025 1:37 pm